New targeted base-editing tool corrects genetic brain disorder in mice
Medical Xpress
February 23, 2026
AI-Generated Deep Dive Summary
Researchers have made a groundbreaking advancement in gene therapy by developing a novel base-editing tool capable of treating Snijders Blok–Campeau syndrome (SBSC), a rare neurodevelopmental disorder caused by mutations in the CHD3 gene. The innovative TadA-embedded adenine base editor (TeABE) was successfully used to correct CHD3 gene mutations in a mouse model, offering hope for treating this debilitating condition.
Snijders Blok–Campeau syndrome is a rare and complex disorder that affects brain development and function, often leading to severe intellectual disabilities and other neurological issues. Mutations in the CHD3 gene disrupt chromatin remodeling, essential for proper brain development, making it a critical target for therapeutic intervention. The TeABE tool represents a significant leap forward in precision medicine, as it allows for precise editing of DNA bases without causing double-strand breaks, minimizing potential off-target effects.
The researchers delivered the TeABE system via a harmless modified virus, ensuring targeted delivery to brain cells in mice. This approach demonstrated efficacy in correcting CHD3 mutations and improving neurological outcomes in the animal model. While further studies are needed to translate this breakthrough into human treatments, the results highlight the immense potential of base-editing therapies for addressing genetic disorders.
This development is particularly significant for patients with SBSC, as current treatment options are limited and largely focus on managing symptoms rather than targeting the root cause. The success of TeABE in mice opens doors for future research into other neurodevelopmental disorders and genetic diseases, showcasing the transformative power of gene-editing technologies. By refining delivery methods and enhancing editing accuracy, scientists may soon bring similar therapies to human patients, offering a path toward more effective and curative treatments.
Verticals
healthmedical
Originally published on Medical Xpress on 2/23/2026